NUWE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Nuwellis Inc (NUWE) does not present a strong buy opportunity for a beginner investor with a long-term focus at this time. While there are some positive financial trends, the lack of significant trading signals, neutral insider and hedge fund activity, and weak growth potential in the short term make it more prudent to hold off on investing in this stock for now.
The MACD is above 0 and positively contracting, indicating mild bullish momentum. RSI is neutral at 61.29, and moving averages are converging, suggesting no clear trend. Key support and resistance levels are Pivot: 1.175, R1: 1.255, S1: 1.095, R2: 1.305, S2: 1.045.
The company announced a software update for Aquadex SmartFlow® aimed at improving patient safety and treatment efficacy. Gross margin improved significantly by 16.93% YoY in the latest quarter.
EPS dropped significantly by -91.81% YoY, and the company is still operating at a net loss despite a 64.92% YoY improvement in net income. There is no significant trading activity from insiders or hedge funds, and no recent congressional trading data.
In Q4 2025, revenue increased by 4.39% YoY to $2,424,000. Net income improved by 64.92% YoY but remains negative at -$2,421,000. EPS dropped significantly to -1.5, while gross margin increased to 68.23%.
No analyst rating or price target changes are available for this stock.
